Research & Development
Our clinical development portfolio across therapeutic areas — from early discovery to approved products.
Pipeline
—
compounds, devices or indications in development individually or under collaboration
Investment
$2M
R&D investment committed to advancing the portfolio
Commitment
—
programs are in mid and late-stage development
Development
—
programs granted a regulatory designation to expedite delivery or review
No pipeline data available.
